Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-02-02 @ 2:28 AM
Study NCT ID:
NCT01824459
Status:
COMPLETED
Last Update Posted:
2019-01-23
First Post:
2013-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Non-intestinal type gastric cancer | View |
| None | Advance Gastric Cancer | View |
| None | Recurrent Gastric Cancer | View |
| None | Gastroesophageal Junction Adenocarcinoma | View |
| None | SOX, S-1+Oxaliplatin | View |
| None | OS, | View |
| None | ORR, | View |
| None | PFS, | View |
| None | TTF, | View |
| None | safety | View |